Arcus kidney cancer drug data published in Nature journal

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/23/2026

1. USO
2. DHR
3. SPY
4. AMD
5. NVDA
6. NOW
7. GM
8. SMCI
9. IBM
10. EFX

Go back to Arcus kidney cancer drug data published in Nature journal
(NYSE: RCUS) Delayed: 29.97 +0.49 (1.66%)
Previous Close $29.48    52 Week High $ 
Open $29.21    52 Week Low $ 
Day High $30.02    P/E N/A 
Day Low $28.68    EPS $ 
Volume 1,035,309